PRCT

Procept Biorobotics Stock Analysis

AI Rating

Fair
  • Quality3/10
  • Growth↑ 6/10
  • Momentum↓ 2/10
Procept Biorobotics sales and earnings growth
PRCT Growth
Good
  • Revenue Y/Y↑ 50.07%
  • EPS Y/Y↑ 22.05%
  • FCF Y/Y↑ 23.02%
Procept Biorobotics gross and profit margin trends
PRCT Profitability
Neutral
  • Gross margin ↑ 64.50%
  • EPS margin↓ -28.20%
  • ROIC↓ -34.40%
Procept Biorobotics net debt vs free cash flow
PRCT Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -22.1

Procept Biorobotics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗